Squamous Cell Carcinoma is the Most Common Malignant Tumor of the Maxillary Sinus
Squamous cell carcinoma accounts for up to 80% of all sinonasal malignancies, with the maxillary sinus being the most frequent site of origin. 1
Epidemiology and Clinical Context
The 2023 ACR Appropriateness Criteria clearly establishes that among epithelial tumors of the sinonasal cavity, squamous cell carcinoma is by far the most common malignancy. The maxillary sinus and nasal cavity together constitute the most common sites of origin for these cancers 1.
Distribution of Sinonasal Malignancies:
- Squamous cell carcinoma: 80% of sinonasal cancers
- Malignant lymphomas: 6-13% of extranodal head and neck lymphomas
- Adenocarcinoma: Less common, often linked to occupational wood dust exposure
- Olfactory neuroblastoma: Only ~2% of sinonasal tumors
- Other rare malignancies: salivary gland tumors, melanoma 1
Clinical Presentation and Diagnostic Pitfalls
These tumors are commonly large at presentation because early symptoms overlap with benign conditions 1. Patients typically present with:
- Nasal obstruction
- Rhinorrhea
- Epistaxis (often unilateral)
- Pain is generally absent until skull base or nerve involvement occurs 1
Critical Caveat:
The proximity of the maxillary sinus to complex skull base anatomy, orbits, and pterygopalatine fossae facilitates early disease extension, which significantly impacts morbidity and mortality 1. This anatomic vulnerability means that delayed diagnosis—common due to symptom overlap with sinusitis—directly worsens outcomes.
Risk Factors Distinguishing Maxillary Sinus Carcinoma
Unlike other upper aerodigestive tract squamous cell cancers, maxillary sinus malignancies have distinct risk factors 1:
- Occupational exposures (particularly for adenocarcinoma subtype)
- Premalignant lesions such as Schneiderian papillomas
- Not primarily tobacco-related (unlike most head and neck squamous cell carcinomas)
Prognostic Considerations
Research data confirms the aggressive nature of maxillary sinus squamous cell carcinoma. A 2024 multi-institutional study of 164 maxillary sinus squamous cell carcinoma cases showed that most patients present with advanced disease (cStage IVa being most common), and the 5-year overall survival was 65.1% with disease-free survival of only 51.6% 2. For patients without lymph node metastasis, aggressive surgical resection of the primary tumor significantly improves prognosis 2.
The rarity of these tumors (only 3% of head and neck carcinomas and 0.5-1% of all malignancies) means that treatment should be coordinated at centers with multidisciplinary expertise 1.